ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Chamberlain, Kupchella Lead Educators; Mattel Donates $25 Million To UCLA Children’s

November 20, 1998

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980